Split History
ETFs Holding LPCN »    LPCN Historical Stock Prices »

Video: What is a Stock Split?

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Lipocine is clinical-stage biopharmaceutical company focused on applying its oral drug delivery technology for the development of pharmaceutical products focusing on neuroendocrine and metabolic disorders. Co. has a license agreement for the development and commercialization its product candidate, TLANDO®, an oral testosterone replacement therapy comprised of testosterone undecanoate. Co.'s additional pipeline candidates, LPCN 1148 comprising a prodrug of testosterone, testosterone laurate, for the management of decompensated cirrhosis. Co. is conducting a Phase 2 POC study in male cirrhotic subjects to evaluate the therapeutic potential of LPCN 1148 for the management of sarcopenia. According to our LPCN split history records, Lipocine has had 1 split.
LPCN split history picture
Lipocine (LPCN) has 1 split in our LPCN split history database. The split for LPCN took place on May 12, 2023. This was a 1 for 17 reverse split, meaning for each 17 shares of LPCN owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 58.8235294117647 share position following the split.

When a company such as Lipocine conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.

Looking at the LPCN split history from start to finish, an original position size of 1000 shares would have turned into 58.8235294117647 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Lipocine shares, starting with a $10,000 purchase of LPCN, presented on a split-history-adjusted basis factoring in the complete LPCN split history. LPCN split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 04/25/2014
End date: 04/23/2024
Start price/share: $127.50
End price/share: $4.80
Dividends collected/share: $0.00
Total return: -96.24%
Average Annual Total Return: -27.95%
Starting investment: $10,000.00
Ending investment: $376.66
Years: 10.00
Date Ratio
05/12/20231 for 17
LPCN is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

LPTN Split History
LPTX Split History
LUX Split History
LXRX Split History
MACK Split History
MBIO Split History
MBOT Split History
MBRX Split History
MBVX Split History
MCK Split History

Also explore: LPCN shares outstanding history

Email EnvelopeFree LPCN Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Applied DNA Sciences, Inc. (APDN)
Cidara Therapeutics, Inc. (CDTX)
Smart for Life, Inc. (SMFL)
Windtree Therapeutics, Inc. (WINT)
Golden Sun Health Technology Group Limited (GSUN)
Zapp Electric Vehicles Group Limited (ZAPP)
Beneficient (BENF)
MySize, Inc. (MYSZ)
Gorilla Technology Group Inc. (GRRR)
Sunshine Biopharma, Inc. (SBFM)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

LPCN Insider Buying

LPCN Split History | www.SplitHistory.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
Wait! Don't leave yet.
Want to receive our latest research absolutely free?

Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.